The Secret reason
why some Doctors
retire so Rich


It has almost nothing to do with a high salary.

Instead, it's a little-known secret of the scientific community, often called the "Doctor's Retirement Package," which is now helping regular people like you and me amass a small fortune... in 2 years or less... beginning with just a few thousand dollars.

  Barron's says, "Few trends are more enticing"... and it "may actually provide just the sort of safe-haven shareholders look for."

That's why I recently paid 2 insiders from the best medical research institution in America to reveal the details...

 

Dear Reader,

It's no surprise that doctors are some of the richest people in America.

But what most people don't know is that many doctors have a secret to getting rich—and it has nothing to do with the money they make from their medical practice...

Take Dr. Patrick Schwartz of Los Angeles. He studied surgery at UCLA... but made so much money from "The Doctor's Retirement Package" that, according to The Los Angeles Times, he and his wife just donated millions to a local hospital.
   
Or Phillip Freeze, who went to Albert Einstein Medical College in Philadelphia, but used the "Doctor's Retirement Package" to make so much money he had an art museum named after him in Florida.

What's interesting is that because of a unique set of circumstances, this doctor's secret can now be used by you, me... or anyone else in America.

Yes, it involves science and medicine... but it doesn't matter how much money you have. It doesn't matter how old you are... or whether you know a syringe from a stethoscope. Consider...

54-year-old David Richards, for example, is from Boston. He's no doctor, but he used the "Doctor's Retirement Package" to make an extra $186,000 since August of 2005, according to government records.
   
Carol Marsden is from Chapel Hill, North Carolina. She never went to medical school, but used the "Doctor's Retirement Package" to make more than $108,000 in the last 6 months alone.

The box on this page lists a small group of other people like you and me  (none are doctors) who have taken advantage of this situation.

"Doctor's Retirement Package" can make you rich—even if you're not a doctor

Here are just a few of the people (non are doctors) who have taken advantage of the “Doctor's Retirement Package” to make a fortune in the past year, according to government records:

Roger Daniels... $27,500 in last 8 mos.
Nancy Depietro... $55,936 since May ‘06
Mitchell Casey... $1 million in 4 mos.
Kris Johansen... $245,000 since May ‘06
Scott Warren... $47,000 since Jan.
Art Cummings... $56,000 in 2 mos.
Stephen Moore... $32,000 since Nov. ‘06
David Sterner... $38,000 in past month
Thomas Garnet... $49,000 in 2 mos.
Mark Kinn... $52,000 since July ‘06

Read on for full details on how to take advantage of the “Doctor's Retirement Package” right now...

How are these folks doing it... and how does the "Doctor's Retirement Package" work? That's exactly why I've written.

You see, as Publisher of one of the leading financial research firms in the country, I see hundreds of new money-making ideas every year. But I've never seen anything like this...

That's why I recently hired two healthcare professionals from Johns Hopkins University, to explain the entire situation in full detail.

What they've uncovered is amazing.

Let me explain how it all works so you can see if it makes sense for you...

How a dishwasher
became a millionaire

All across America, doctors, their friends, and colleagues have been using the "Doctor's Retirement Package" to accumulate enormous sums of wealth, very quickly.

What's amazing is that most of these folks never set out to get rich.

In fact, most never heard of the "Doctor's Retirement Package" — until one day, when it practically fell into their lap...

Consider Herbert Boyer, for example, a bright and idealistic young man from Pennsylvania.

Boyer graduated from St. Vincent College. He wasn't sure what to do next. He wasn't seeking fame or fortune, so he continued his education at the University of Pittsburg, then landed a job as a professor at the University of California, San Francisco.

Dr. Boyer earned a decent living. But he was by no means rich.

That all changed when one day, at a scientific conference in Hawaii, Dr. Boyer met a likeminded Stanford University professor — who shared Boyer's passion for a niche field of medical research. The pair hit it off immediately, and quickly ducked out of the conference to have lunch across the street at a Waikiki Beach deli.

There, they hatched a plan to collaborate on a cutting edge scientific technology called "Recombinant DNA."

I know... this might mean nothing to you or me, but Dr. Boyer and his colleague knew their work could one day save countless lives.

That's because Recombinant DNA, which allows you to combine the DNA of two different organisms, has hundreds of applications in science and medicine, including the manufacture of vaccines and insulin.

After helping his university earn more than $200 million in patent royalties, Boyer decided his breakthrough could do even more in the private sector.

So he took $500 and started a business based on his research. As a result Dr. Boyer won countless awards, and helped thousands of sick people get better. Along the way, he also made millions.

Of course, the people in Dr. Boyer's circle of friends and colleagues didn't do too bad either. If you owned just 100 shares of Boyer's company when it went public, you'd now have more than $430,000. If you owned just 300 shares, you'd be worth well over $1 million.

Look at just a few of Boyer's friends and colleagues who got in on the deal over the years:

Susan Desmond-Hellmann is a fellow doctor who has known Boyer for 12 years... she's made well over $1 million as a result of their relationship.
   
Ian Clark has been one of Dr. Boyer's colleagues for the past four years... and has made more than $350,000.
   
Stephen Juelsgaard is lawyer who has known Dr. Boyer for the past 22 years. On January 12th of this year he received a one-day payout of about $88,000.

Do you see how it works?

These extraordinary profits are made possible because the tight-knit medical community is always one step ahead of Wall Street when it comes to which medical technologies will ultimately work, and which ones won't.

Let's face it—no one knows better than the people in the labs and hospitals, which new medical technologies are going to be worth a fortune... and which are going to be sent back to the drawing board.

Sometimes, doctors and scientists start a new business based on their best discoveries. They—and their friends and family—can often walk away millionaires, very quickly.

Other times, doctors and scientists simply see what's happening in their field firsthand—and they invest in a group of leading innovators, which they know from personal experience will be winners.

These profitable investments are made possible only because of their work and connections in the medical world.

This, in short, is what's often called "The Doctor's Retirement Package." It's how many doctors retire rich—even if they never make a lot of money from their medical practice. And it's how many of their friends and families earn a fortune as well, even if they've never stepped foot in a lab or research center.

It actually happens quite often in the medical community...

** A Southern California man named Bill Bowes knew that many of his scientist friends were doing breakthrough work on human hormones, which could be used to treat anemia in cancer and dialysis patients. He put together a company that turned every $100 invested into more than $15,000.  

According to a local California newspaper, Bowes' dishwasher friend used this investment to become a millionaire.

** A surgeon named Dr. Frederick Moll had a new idea for a computerized surgical tool while working in Seattle. Over the past four years, every friend and colleague who invested $1,00o with Moll at the beginning has seen his or her stake go up 20-fold.

Of course, the question is: How can you take advantage of the "Doctor's Retirement Package," even if you're not a doctor or scientist... and even if you don't have any close friends in the scientific community?

That's the whole point of this letter. Let me explain...

How to retire in
2 years or less...

My name is George Rayburn. I run one of the biggest financial publishing firms in the country, called Stansberry & Associates Investment Research.

I've invested a lot over the past 12 months uncovering exactly how the idea behind the "Doctor's Retirement Package" works.

Unfortunately, most of the time these investments are completely off limits, unless you have a close friend or family member in the medical community.

The good news is that I know two well-connected men in the scientific community who are putting together a "Doctor's Retirement Package" right now.

You will never hear about this deal on your own... or from any financial planner or stock broker. It will never be published in any newspaper or magazine.

But I'll tell you all about it now—right here in these pages. I think you'll be interested, because it has the potential to make you very wealthy over the next few years...

One of the guys putting together this "Doctor's Retirement Package" has an MBA and a Masters in Public Health from Johns Hopkins. He worked in the Comprehensive Prostate Cancer Research Program at Cedars-Sinai Medical Center in LA, and also at a biotech firm outside of DC (he also helped the firm set up a division in Hyderabad, India).

The other fellow has a PhD in Biochemistry, worked at a biotech firm in Canada, speaks three languages, and has been published in the four best scientific journals in his field.

Let me tell you more about these guys and the "Doctor's Retirement Package" they've organized...

Up 1,000%, in as
little as 6 months

During the course of their work over the past few years, the two fellows I just described, Rob Fannon and Dr. George Huang, have witnessed a radical medical trend that is sending shockwaves throughout the healthcare community.

They are putting together a "Doctor's Retirement Package" to take advantage of the situation.

In short, after spending years using this technology and watching it develop in hospitals, labs, and universities, they have hand-picked the best companies, which will make some investors quite wealthy in the coming years.

In a nutshell, the medical breakthrough I'm talking about is actually a collection of new technologies, often referred to as "Personalized Medicine." In short, Personalized Medicine allows doctors to diagnose and treat diseases based on your personal genetic makeup and unique biomarkers.

In other words, this is medicine on the molecular level—a huge advance that has already been approved by the FDA, and is being used in some form in every major hospital in America.

Keep in mind—Rob Fannon and Dr. Huang did not invent these technologies. But they have spent hundreds of hours in the lab using these breakthroughs...

They've done genotype and gene sequencing work... performed immunoassays... run molecular protein tests such as the Bradford assay... used Spectroscopy for chemical analysis... replicated DNA without live organisms... the list goes on and on.

They've also presented their work at scientific conferences around the country... have contracted with the National Institutes of Health (NIH) for follow-up work to the Human Genome project... and have worked side-by-side with Nobel Prize-winning genetic scientists and doctors at the best universities and hospitals in the country, just to name a few.

And while it's unlikely that you've heard of these Personalized Medical breakthroughs yourself, these developments are causing a huge stir in the scientific community...

Dr. Francis Collins of the National Institutes of Health (NIH) calls it a "historic movement... a revolution."
   
Kenneth Conway, a scientist at a Massachusetts healthcare firm, who is using one of these new genetic technologies to treat cancer says: "We are going to change the diagnosis of cancer—and change the practice of medicine."
   
Dr. John P. Kane of the Univ. of Cal. San Francisco Cardiovascular Research Institute is using one of these new molecular technologies to treat heart disease. He says: "We're embarking onto the open sea... and we're discovering things that nobody knew about."

The point is, this is by far the biggest trend in medicine right now.

All you have to do is look at the funding pouring in to see what I mean (see the box below).

Using these new technologies, doctors can now diagnose many diseases very early in their progression, simply by looking at your genes and certain biomarkers in your blood. They can even tell which diseases you are likely to get in the future!

This is where the money
is right now. . .

Money for "Personalized Medicine" is pouring in. Look at just a few of the grants announced since September 2006:

The National Institute of Health gave huge sums to The Broad Institute ($200 million), the Washington University School of Medicine ($156 million), and Baylor College of Medicine ($114 million) to find genetic links to diseases.
   
The Virginia and D.K. Ludwig Fund for Cancer Research gave Johns Hopkins $20 million to study the genetics of cancer tumors.
   
Regeneron Pharmaceuticals was awarded $17.4 million from the National Institutes of Health to accelerate the understanding of genetic diagnostics.
   
The U.S. National Eye Institute is giving the University of Iowa $14.6 million to study genetic treatments for age-related macular degeneration (AMD).

The point is, this is where the money is... and where it's going. You stand to make a fortune over the next few years with just a few simple investments today.

As The Economist recently wrote: "you will not have to spend hours in a doctor's office to complete a comprehensive health check-up. Instead, with just a single pin-prick... based on this ‘molecular fingerprint,' your doctor will prescribe drug regimens tailored to your personal state of health that will not only be able to reverse many diseases, but will also prevent their manifestation in the first place."

Obviously, these "Personalized Medicine" breakthroughs are worth a lot of money. Already, several companies involved have shot up 1,943%... 604%... and 706%, in as little as 6 months.But as I'll show you, these gains are just the beginning...

As I mentioned, not 1 in 1,000 Americans knows about these developments yet.

I know about them only because I spent a fortune hiring two well-connected guys in the healthcare field. They know about them only because they are insiders.

That's why you can make a heck of a lot of money by taking advantage of Rob Fannon's and Dr. Huang's Personalized Medicine "Doctor's Retirement Package."

Let me show you more specifically what I mean...

What smart (and wealthy)
doctors are buying right now

This technology might sound space-age. And it was, just a few years ago.

But today it is very real—and is taking place in every major medical center in America. It's also just starting to make some early investors quite wealthy:

A California company that makes FDA-approved gene-testing machines has shot up 1,943% in recent years.
   
A company called Meridian Health has developed molecular tests for viruses and bacteria, and also stomach ulcers and food poisoning. The stock is up 706%.
   
A company called Dade Bearing Holdings has developed some popular genetic diagnostic equipment. Since the company went public, the stock has shot up about 354%
   
A company called Immucor sells equipment to test for all kinds of diseases and ailments, by looking at an ordinary blood sample. The company's shares have shot up 604%.

From their work in medical labs, universities, hospitals, and private sector biotech firms, Rob Fannon and Dr. Huang have created a "Retirement Package" of 6 companies that are now leading the way in new Personalized Medicine technologies.

Here they are:

Doctor's Retirement Package Company #1 is the best diagnostic company in America. The company is a leader in a molecular testing technique called ELISA, which Rob Fannon has used personally in the lab. This company has cutting-edge genetic tests for leukemia, colon cancer, heart attacks, arthritis, and liver disease.

This business performs about 500,000 tests each night, with results available the next day. They serve 50% of the doctors and hospitals in America. Rob Fannon and Dr. Huang believe this is a company you should buy immediately, and hold for the next decade.

As this company has perfected their technologies over the past few years, the stock has moved steadily up, gaining 76% since 2003.

Doctor's Retirement Package Company #2 is a small company that is on the cutting edge of something called Polymerase Chain Reaction (PCR) tests, which both Rob Fannon and Dr. Huang have used hundreds of times in their careers. This company has developed molecular tests for micro-organisms that cause a range of ailments, including tuberculosis, strep throat, pneumonia and sexually transmitted diseases.

This company has been on a steady climb for the past few years. It's up 44% since 2004, and has a long, long way to go. In fact, the company's work is so important that President Bush gave them the National Medal of Technology—our country's highest honor for technological innovation. Prior winners include DuPont, IBM, Johnson & Johnson, Merck, and 3M.

Doctor's Retirement Package Company #3 developed an FDA-approved "GeneChip" system to analyze complex genetic information. Rob Fannon knew about the company because the technology was used in the labs down the hall from his office at Cedars-Sinai Hospital in California. In the past 4 months the stock is up about 30%.

Doctor's Retirement Package Company #4 is a San Diego Company that has developed a revolutionary biomarker rapid-testing system for heart attacks and cardiovascular disease. Rob and Dr. Huang have used these same basic screening assays many times in the lab over their careers. In the past 7 months this stock is up about 38%.

Doctor's Retirement Package Company #5 is a business that has the only FDA-approved, 2-minute mouth-swab test for one of the world's deadliest diseases. This company's product is being used by hundreds of clinics and hospitals in America, but it is still almost completely unknown outside of the medical community.

Rob Fannon and Dr. Huang know from their lab work that this is a revolutionary development in antibody detection—every doctor and scientist would rather work with low-risk buccal cheek cells, rather than potentially infectious blood.

Doctor's Retirement Package Company #6 has developed some of the most advanced genetic testing technologies in the world. This company licenses patents and is performing tests in conjunction with Johns Hopkins University—where both Rob Fannon and Dr. Huang received their advanced degrees. Since the beginning of 2006, the company's shares are up about 60%.

Every single one of these companies has a new Personalized Medicine technology that is being used in the real world, right now.

You can see that all of these stocks are moving higher—some very quickly.

And you can see that Rob Fannon and Dr. Huang have personal experience will all of these technologies. That's critical, because you simply couldn't know about and understand these developments... unless you've done this kind of work yourself in the real world.

In short, this "Doctor's Retirement Package" is a collection of 6 companies you should own over the next few years, which could very well give you enough money to live on for the rest of your life.

Everything you need to know about all of these companies is covered in Rob Fannon's and Dr. Huang's new Research Report called: The Doctor's Retirement Package.
 
As you'll see, there are two companies Fannon and Dr. Huang recommend you buy immediately, and 4 others to buy over the next few months.

There's no guarantee, of course, how high these companies will go up over the next year or so, but other companies that have developed Personalized Medicine breakthroughs have gone up 500% or more in just a few years.

The bottom line is, this "Doctor's Retirement Package" put together by Rob Fannon and Dr. George Huang can help you amass a small fortune, fairly quickly.

Remember, it's all made possible only because the tight-knit medical community is always a step ahead of Wall Street when it comes to which medical technologies will ultimately work, and which won't.

I'd like to send you Rob Fannon's and Dr. Huang's full Doctor's Retirement Package Research Report on this situation, right away—and free of charge. I believe the sooner you invest, the more money you will make.

How can you get your free copy? Let me show you...

How to make 500% over
the next two years

As I mentioned, I'm the Publisher of a Baltimore-based firm called Stansberry & Associates Investment Research.

We started this business a little more than six years ago—and have already become one of the top-3 independent Investment Research firms in America, in terms of size and numbers of subscribers.

The secret to our growth and success is that we hire the best investment analysts in the country—former Certified Financial Planners, stockbrokers, mutual fund managers, hedge fund mangers, bond traders, geologists, chemists, medical doctors, MBAs, etc.

Just this month, for example, one of my PhD analysts traveled to Japan. One is in Florida. Another has gone to Oregon. Two others went to California. And two others are off to Switzerland. All in search of great investment ideas, which we share with our paid subscribers.

Our analysts have been profiled in Barron's, The Wall Street Journal, and more than a dozen other publications. But what we're most proud of is how we've helped many people change their lives, by showing them how to safely make more money than they ever imagined possible.

For example, a subscriber named Jack Marks, from Pittsburgh, wrote to tell us he made 340% on a recent recommendation. He added: "I suppose... a house in Hilton Head may still be in the cards for me."
   
A subscriber named Clyde Lafond, 68, from Burbank, CA, wrote to tell us: "My $600,000 is now worth well over a $1,000,000. I think that I am almost ready to retire."
   
A subscriber and retired cardiac surgeon named R. C. Beck recently told us: "I took my wife's portfolio from her advisor and quadrupled it."

Right now, we believe some of the absolute best investment opportunities in the world right now are in healthcare and medicine.

That's why, about a year ago, I hired Rob Fannon and Dr. Huang—two of the most well-connected healthcare insiders in the country.

I brought these guys on to investigate medical and healthcare investment opportunities, and then to share their insights with our readers in a monthly publication called The Medical Investor. In the past year they've visited more than a dozen companies in person, and have attended the healthcare industry's biggest events (I'll give you more details in a minute).

One of the opportunities Rob Fannon and Dr. Huang are most excited about right now are the group of companies they've put together in their new Doctor's Retirement Package.

They've seen firsthand how these genetic technologies are revolutionizing medicine... and are making early investors rich. It's still early in the game. You have time to get in and make a fortune in the coming years.

This is how savvy doctors and scientists retire rich—there's no reason for you not to do the same. That's why I want to send you, free of charge, their new Research Report called: The Doctor's Retirement Package.

In exchange for receiving this Research Report free of charge, all I ask is that you try a no-risk trial subscription to Rob Fannon's and Dr. Huang's research—The Medical Investor—our newest and most-exciting publication.

I'll tell you more about these guys and The Medical Investor in a minute.

But first, let me tell you about another great investment opportunity Rob Fannon and Dr. Huang have uncovered recently...

The hidden secrets of
America's healthcare fortune

Did you know that 16 cents of every dollar made in America goes to healthcare? Incredible.

But if you're like me, you've probably wondered... where does all of this money go?

Well, a lot of it goes to doctors, hospitals, and drug and insurance companies. That's no surprise.

But what most Americans don't know is that a handful of secret medical businesses you've probably never heard of get the rest. We call these companies "The hidden secrets of America's healthcare fortune."

For example...

Did you know that every time someone in a nursing home takes a pill, chances are good that a Kentucky business called Omnicare Inc. makes a profit?

It's like a nationwide drugstore for nursing homes — and a very profitable one, because Omnicare's contracts include roughly half the nursing home beds in the country.

If you knew this hidden secret of the healthcare world, you could have made 409% in a four-year span... and 1,995% over roughly the past 16 years.

The point is, these "hidden secrets" in the health care world are companies you won't read about on the front page of The Wall Street Journal. There's nothing sexy about what they do...

Except that they make incredible profits for shareholders.

The only way you're going to hear about these secret opportunities is through a reliable industry insider...

That's why I hired Rob Fannon and Dr. Huang, who recently told me about the best "hidden secret" in the healthcare field right now, which you can profit from beginning immediately...

The most profitable healthcare
Secret in America

Did you know that when a biotech or pharmaceutical company wants to test a new drug, they usually hire an outside company to perform the actual tests?

These testing firms are middlemen who find doctors, recruit patients, and compile the data.

What's great is, these testing firms make huge profits, whether a drug passes or fails its test!

Imagine if you could make money on every drug that's tested, whether it passes or fails. That's essentially what these testing companies do. It's low risk... and high reward for owners and shareholders.

The way I look at it is, let other people gamble on whether or not a new drug will succeed or fail... I'd rather take the sure thing and get paid every time a drug is tested.

"There's a secret way
to make large profits, even if a new drug fails its FDA tests."

What's exciting is that there are two companies dominating this business in America.

One of these companies specializes in the Early-Stage Tests (Phases 1 and 2) of new drugs. The other specializes in Late-Stage tests (Phase 3).

And get this: These companies test the majority of new drugs. Their net revenues have each increased by about $100 million for five straight years.

So it's no surprise that these companies are virtual cash machines for shareholders. One company has returned 470% gains since the beginning of 2000. The other has returned about 150% since the beginning of 2004.

If you want a simple and safe way to make a fortune over the next few years as more and more drugs get tested, this is the best way to do it.

There's no guarantee as to how many drugs will get approved each year—but there is a guarantee that every drug must pass full FDA tests before it can be sold. And the companies that provide these services will keep profiting exponentially.

Barron's reports that: "Demand [for these testing services] is on the rise. More drugs are now in development and need testing, and big drug makers, including Pfizer and Johnson & Johnson are outsourcing development-related work to cut costs and speed along drug approvals."

One of the companies I'm going to tell you about has a $2.24 billion-dollar backlog of business—a 24% increase from the year before. The other company has a backlog of $2.2 billion worth of business, a 33% increase from the year before.

The point is, these companies are growing moneymaking machines—and offer you a super-safe way to make outstanding returns for the next few years.

Rob Fannon and Dr. George Huang have written a special Research Report to help you take advantage of this situation immediately. It's called: The Big Hidden Secret of America's Healthcare Fortune. When you take a trial subscription to The Medical Investor, you'll receive a copy of this new Report, free of charge.

How will you know if The Medical Investor is right for you?

Let me explain why we started it, which should help you decide whether or not to give it a try...

Where the money is going
in America right now

I'm not sure if you are aware of this or not, but healthcare is by far the fastest-growing industry in the U.S. ...

A recent BusinessWeek article detailed how, since 2001, 1.7 million new jobs have been added to the healthcare sector. Guess how many jobs have been added in the rest of the economy? Zero. As the magazine reported: "Healthcare has become the main American job program for the 21st century."

The Department of Labor projects a 30.3% increase in the number of healthcare jobs between now and 2014. That's 4.7 million new healthcare jobs!

Why is this happening?

One of the biggest reasons is because almost every major city in the country is pouring millions into new biotech businesses, medical research facilities, and high-tech hospitals:

- Philadelphia is spending $1.7 billion to expand its leading pediatric center, and is adding a $1.2 million research facility. A Philadelphia hospital administrator says: "Healthcare is the major engine for the economy of the city of Philadelphia."

- California will pour $3 billion into biotech research over the next 10 years.

- Cleveland has formed a group called Bioenterprise, a consortium of hospitals, universities, and healthcare companies to attract grants and business to the area. So far they've attracted more than $300 million in funding.

- Baltimore "is uniquely poised to become the Silicon Valley of biotech," reports The Sun, the city's biggest newspaper.

- The Chicago Tribune reports their city "is ripe to become a biotech powerhouse... "

The point is... U.S. healthcare is where the money is right now... and where the money will keep going for the next 5 years at least.

It's also one of the best places for investors to make big returns...

For example, did you know that 3 of the top 5 investments over the past six months were in the healthcare field?

One of these companies, called Carematrix Corp, which provides assisted living to seniors, returned well over 5,000% during the last 6 months. The other two top healthcare returners provided gains of well over 1,000% apiece, during the same time.

The long-term numbers are even better...

Since 1973, healthcare stocks (measured by the Datastream Healthcare Index) have beaten the stock market in general (as measured by the S&P 500 Index), by a whopping 875%!

"Since 1973, healthcare stocks have beaten the overall stock market by a whopping 875%"

As Liu-Er Chen, a manager at Evergreen Funds in Boston, says: "Over the past 10 or 15 years, healthcare stocks have significantly outperformed the S&P 500, and the future long-term results should be similar or even better, for obvious reasons."

What are these "obvious" reasons?

Well, the biggest is the major demographic shift taking place in America right now: Baby Boomers are retiring, and they will spend much more money on medical care in the coming years than they ever have before.

As The New York Times recently reported: "Baby boomers are descending upon the healthcare infrastructure of the United States like locusts upon a cornfield.''

Again, healthcare is where the money is right now—and it's where the money is going over the next 5 years and beyond.

You can make a lot of money with the best healthcare investments, no matter what's happening with the rest of the economy or the stock market.

That's why, for the past year, we've been working on our newest investment research publication, The Medical Investor. Most of the investments we recommend will be in the United States, but Rob Fannon and Dr. Huang will also recommend great opportunities when they find them overseas.

We're publishing this research because we believe healthcare is the best place to make a lot of money in the coming years... and because, as the editors of Financial Planning recently wrote: "The healthcare sector is... relatively recession-proof. If people are sick and can afford healthcare, they won't skimp on it just because the market is down or the economy is weak."

That's why we've spent a fortune hiring the best analysts in the business...

Harvard doctor helps make
100% gains in one day

I mentioned earlier how Rob Fannon has an MBA and Masters in Public Health from Johns Hopkins University. How he's worked in the lab of one of America's best hospitals, and even helped set up a biotech firm in India.

I also described how Rob's Assistant, Dr. George Huang, has worked at biotech firms and top universities in the U.S. in Canada.

What I didn't tell you is how good these guys are at using their inside contacts to find great investments...

From his work in genetics, Rob told us about a radical new medical treatment called RNAi, which is being used to treat several major disorders. After consulting with Dr. Judy Lieberman — a Professor of Medicine at Harvard University... and a patent attorney, Rob added an RNAi company called Sirna to his portfolio. Just 6 months later, it was bought out by Merck — and the stock DOUBLED OVERNIGHT. Those who got in at our original recommendation, made 203% gains. Rob added another RNAi company called Alnylam Pharmaceuticals (ALNY) to the portfolio. So far the stock is up 43%... with a long way to go.
   
Likewise, Rob's connections with world-famous heart doctor P.K. Shah at Cedars-Sinai Hospital led us to recommend a company called Esperion, which developed a new way to treat heart disease. Rob worked in a lab down the hall from Shah, who was involved in early research that went into the company. Three weeks after we recommended Esperion, the stock jumped 55% overnight, when is was bought by Pfizer.
   
Rob used his connections at Johns Hopkins to learn about a new vaccine technology called PER.C6, which is being licensed by dozens of big companies. In fact, Rob even set up a meeting between the company behind it (called Crucell) and the university. Since we recommended Crucell, our readers have had the chance to make gains of 292%

Keep in mind, Rob Fannon has only been with our firm as a full-time analyst for one year. In that short time he and Dr. Huang have visited health care and medical companies in North Carolina, San Francisco, Vancouver, San Diego, Boston, Atlanta, Baltimore, and New York.

They've been to all of the indutry's big meetings: The Biotechnology Industry Organization conference in Philly... the American Association of Cancer Research conferences in D.C., San Fran., and Orlando... the Experimental Biology Conference in San Francisco... the American Society of Hematologists Conference in Orlando.

Plus they've been to specialized medical meetings such as the American Association for the Study of Liver Diseases in Boston... and they'll soon be traveling to the American Society for Clinical Oncology conference in Chicago.

If you were in my position, wouldn't you have hired them too?

They're smart, well-connected, and work hard to find the best investments in medicine and healthcare.

What I also like about Rob Fannon and Dr. Huang is that they are scientists, not stock promoters. So they're both extremely skeptical and conservative.
Every recommendation they make will offer you a conservative way to take advantage of the boom in the healthcare industry.

That's one of the reasons why, already, in the limited research Rob Fannon and Dr. Huang have done in the past year, the response from our readers has been incredible...
  

"In 30 years of subscribing to advisories, [Rob Fannon's] is by far the best in my judgment. My portfolio has a $32,487 profit in less than 6 months."
- Jack Milligan, Memphis, TN
 
"Your service is without a doubt the best I have used. In fact, I have eliminated all the others. Keep up the good work!"
- Gerald Sinclair, Delray Beach, FL
 
"In 6 months, I am already up 82.3%... 42.3%... and 40.8% on your recommendations. Your team is doing a great job. I am learning more than I expected... especially opportunities that I would otherwise never hear about. I am very happy..."
- Steven Stockton, Henderson, NV
 
"In 2 ½ months, I have already made a 125.3% gain... easily the best-performing newsletter among the many that I'm subscribed to."
- Sam Quincey, Santa Cruz, CA

We believe the past year has been a great test for Rob Fannon and Dr. Huang.

That's why we are excited to invite you to become a charter subscriber to their brand-new service, called The Medical Investor.  In fact, look at a few of the other moneymaking opportunities these guys are looking at right now...

The only legal monopoly in America. Did you know that the only legal monopoly you can have in America is in a specific sector of the healthcare field? Thanks to the U.S. government, a handful of companies have used this law to secure stock market gains of more than 1,300%. In The Medical Investor, you'll learn about this legal monopoly, and how you can use it to make a fortune in the coming years.

The only drug company you need to own. There's one drug company that is head and shoulders above the rest—it's one of the biggest and most profitable makers of generic and brand-name drugs. Surprisingly, you've probably never heard of it before. This company has been going steadily up for the past 5 years, with gains of almost 100%. You can buy it today, forget about it for the next decade, and make a lot of money in dividends and capital gains.

In fact, Rob Fannon and Dr. Huang just recommended this company in their Feb. 2007 issue of The Medical Investor. You'll have instant access to this report as soon as you subscribe.

Of course, these opportunities to make safe profits in the health care sector are just the beginning.

When you take a no-risk-trial subscription to The Medical Investor, you will receive:

Every month, Rob Fannon and Dr. George Huang will send you a full report on their best healthcare investment idea. You'll receive this Report by e-mail at approximately 6pm, on the 2nd Wednesday of every month.
   
Investment Report: The Doctor’s Retirement Package. For years, doctors and scientists have retired rich by taking advantage of the best medical breakthroughs, long before the average investor even knows they exist. Here’s your chance to get in early on the biggest and most important trend in the medical community. There are 2 companies you should buy immediately, and 4 more to add in the coming months.
   
Investment Report: The Big Hidden Secret of America's Healthcare Fortune. There's a secret way to make several times your money over the next few years, in a little-known health business that is making investors a fortune.
   
E-mail Updates. When you take a subscription to The Medical Investor, you'll also receive daily e-mail updates on what Rob Fannon, Dr. Huang, and the 8 other analysts in our business are pursuing.

Keep in mind that when you sign up to take a risk-free trial subscription to The Medical Investor, you will have the next six (6) months to decide if it's right for you. 

We want you to be happy with our work. And there's no sense doing business together if you're not. That's why you can try The Medical Investor for the next six months at no risk. If you're not happy for any reason, you can get a full refund.

So how much does it cost to receive The Medical Investor and everything else mentioned here?

I think $1,000 per year is a fair price, based on the value of this work, and the cost of putting it together. Rob Fannon and Dr. Huang have charged as much as $5,000 a year for their work.

But right now we are temporarily offering Rob Fannon's and Dr. Huang's Research for significantly less.

Before I give you the details... let me tell you about one more thing you'll receive with your subscription.

It's the full details on what could easily be the most profitable stock in the market over the next 12 months...

How to make 619% in 2 years

Investing in new medical devices is one of the best ways to get rich in the stock market. (See the sidebar below for a few examples of what I mean.)

That's why Rob Fannon and Dr. George Huang are so excited about a tiny company that has developed a radically new and totally safe way of taking pictures inside of your body.

How to make 4,247%
in the medical world

Great new medical devices can be very lucrative for small companies and their shareholders. Consider...

Investors in a company called Intuitive Surgical (which developed a new device for urologic, cardiothoracic, gynecologic, and general surgeries) have made 1,533% since the beginning of 2003.
   
Investors in a company called Angeion Corp. (which developed a non-invasive cardio-respiratory diagnostic device) have made 619% since the beginning of 2005.
 
And investors in a company called Palomar Medical Technologies (which developed a light-based treatment for varicose veins, acne, and other problems) have made an incredible 4,247% since the beginning of 2002.
 
Now, Rob Fannon and Dr. George Huang believe they have found the next big medical device breakthrough. You'll get a copy of their full Research Report on the subject, called: The Most Profitable New Medical Device Investment in the World Right Now, as soon as you take a trial subscription to The Medical Investor.

It's safer than X-Rays, MRIs, or CAT Scans, and is already approved by the FDA. So far, this new technology has been used on 450,000 patients worldwide, with amazing results for certain cancers and many gastrointestinal problems...

When a patient named Matthew Anci was treated with the device, he said: "It changed my life completely. It really did save my life... "

The small company behind this new invention has 43 patents in the United States, Europe, Japan, Australia, and elsewhere around the world. Their new invention has been profiled in Nature, the most important journal in the medical industry, three times (volumes: 405, 417, and 438).

Still, the company is almost completely unknown, despite the fact that the share price has already started to climb... up about 25% since last summer.

Even better, this tiny company has a $50 million marketing deal with Johnson & Johnson, the biggest medical device company in the world.

Unfortunately, I can't be any more specific here. What I can say is that I believe you will be shocked when you see how radical this new device is. I was so impressed I had one of my researchers contact the company to see which doctors in my area are using it. Turns out there are 22 nearby, including doctors at Georgetown Medical Center, Sinai Hospital in Baltimore, and Johns Hopkins Hospital.

When you subscribe to The Medical Investor, you'll be among the first to get all the details, when Rob Fannon and Dr. Huang send you their latest report, called: The Most Profitable New Medical Device Investment in the World Right Now.

This Research Report, like everything else I've described in this letter, is free with your trial subscription to The Medical Investor.

As I mentioned, Rob Fannon and Dr. Huang charge as much as $5,000 for their research.

Right now, we're charging Charter Subscribers just $199 for a year of The Medical Investor, including everything else I mentioned in this letter. We will soon begin charging considerably more than this introductory rate.

When you see the amount of work Rob Fannon and Dr. Huang do on every recommendation they make... and the very nice investment gains that pile up every single month, I think you may agree with me that this might be the most under-priced investment research in the country.

To get started right away Subscribe Now

Sincerely,

George Rayburn
Publisher, The Medical Investor

P.S. By ordering now you will have online access to everything described here in the next 15 minutes.

Subscribe Now